In a recent article
in The New York Times, Dr. Gretchen Schwarze discusses the controversy surrounding the use of 30-day mortality as a surgical success measure. Focusing on reducing 30-day mortality, which is frequently used in the public reporting of quality and, more recently, to determine Medicare penalties, can result in diminished quality of life for patients after surgery and result in surgeons declining to operate on high-risk patients.
